Meeting
2018 ASCO Annual Meeting
Post-treatment evaluation of head and neck cancer patients in the era of advanced imaging and value-based care.
Authors
Thomas Hirsch
Medical College of Wisconsin, Milwaukee, WI
Thomas Hirsch , Michael Stadler , Bruce Campbell , Selim Firat , Becky Massey , Christopher J. Schultz , Monica Shukla , Stuart J. Wong , Jared R. Robbins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6079)
DOI
10.1200/JCO.2018.36.15_suppl.6079
Abstract #
6079
Poster Bd #
67
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using 18F-BMS-986229 PET.
First Author: Samuel Louis Cytryn
Poster
2022 ASCO Quality Care Symposium
Defining key care events to integrate biomarker testing in the workup for patients with advanced non–small cell lung cancer (aNSCLC).
First Author: Nikki A. Martin
Poster
2022 ASCO Annual Meeting
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC).
First Author: Shivanshan Pathmanathan
Poster
2021 ASCO Annual Meeting
Imaging HER2-positive metastatic esophagogastric cancer with 89Zr-trastuzumab PET and 18F-FDG PET.
First Author: Melissa Amy Lumish